Opportunities In Private Healthcare In China
TUESDAY, APRIL 22, 2014, KUALA LUMPUR: Malaysia External Trade Development Corporation (MATRADE) today released a statement saying that China is encouraging more private sector investment in China’s healthcare.
According to MATRADE, the new measures was jointly announced on the 9th April 2014 by the National Development and Reform Commission (NDRC), the National Health and Family Planning Commission and the Ministry of Human Resource and Social Security aimed to increase and improve the supply of medical services in China which help to ease the problem of inadequate health provision available to the public.
China has invested approximately RMB 3 trillion (US$488 billion) into its medical care reform over the last five years. By the year 2015, the market size of medical devices and equipment in China is expected to reach US$53.70 billion.
Senior Trade Commissioner of MATRADE Beijing, Mr. Abu Bakar Yusof said, “Malaysian private healthcare services provider should penetrate China healthcare market now since China is currently welcoming more vigorous participation of non-government capital to take part in the healthcare reform. The demand for high quality healthcare services by the Chinese affluent society show there is also a need for high quality health services and supply of medical devices and equipmentâ€.
Among the high demand products include chromoscope ultrasonic diagnostic equipment, syringes & needles & catheters & cannulae, computed tomography apparatus, medical or veterinary X-ray applications and appliances for redeeming physical defects and disabilities.
The major countries supplying are USA, Germany, Japan, Switzerland, Ireland, South Korea, UK, Netherlands, France and Singapore.
